| Aktie | Ticker | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 172.378.588 $ | +66.023.118 $ | +24,0 % | 106.465.070 $ | +6.873.191 $ | +7,9 % | 101.235.881 $ | +4.028.554 $ | -30,3 % | ||
| BANK OF AMERICA CORP /DE/ | BAC | 167.015.068 $ | +62.770.048 $ | +60,2 % | 104.245.020 $ | +4.751.841 $ | +4,8 % | 99.493.179 $ | +3.695.193 $ | +3,9 % |
| Syndax Pharmaceuticals Inc | SNDX | 2.731.300 $ | +731.250 $ | +36,6 % | 2.000.050 $ | +2.000.050 $ | ||||
| KAZIA THERAPEUTICS LTD | KZIA | 2.067.000 $ | +2.067.000 $ | |||||||
| NEKTAR THERAPEUTICS | NKTR | 1.292.000 $ | +1.292.000 $ | |||||||
| GROUP ONE TRADING LLC | 482.020 $ | +482.020 $ | ||||||||
| KIORA PHARMACEUTICALS INC | KPRX | 352.002 $ | -15.889 $ | -4,3 % | ||||||
| PRECISION BIOSCIENCES INC | DTIL | 83.200 $ | -27.200 $ | -24,6 % | 110.400 $ | +110.400 $ | ||||
| GERON CORP | GERN | 109.600 $ | +10.900 $ | +11,0 % | 98.700 $ | -942.750 $ | -90,5 % | |||
| 172.378.588 $ | +66.023.118 $ | +24,0 % | 106.465.070 $ | +6.873.191 $ | +7,9 % | 101.235.881 $ | +4.028.554 $ | -30,3 % | ||